检索结果 - Ghady Haidar
- Showing 1 - 20 results of 27
- Go to Next Page
-
1
-
2
-
3
-
4
COVID-19: Challenges of Viral Variants 由 Jana L. Jacobs, Ghady Haidar, John W. Mellors
出版 2022Revisão -
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
Association between the Presence of Aminoglycoside-Modifying Enzymes and <i>In Vitro</i> Activity of Gentamicin, Tobramycin, Amikacin, and Plazomicin against Klebsiella pneumoniae... 由 Ghady Haidar, Ammar Alkroud, Shaoji Cheng, Travis M. Churilla, Bryce M. Churilla, Ryan K. Shields, Yohei Doi, Cornelius J. Clancy, M. Hong Nguyen
出版 2016Artigo -
13
Verification of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Susceptibility Testing Methods against Carbapenem-Resistant Enterobacteriaceae and Pseudomonas aeruginosa 由 Ryan K. Shields, Cornelius J. Clancy, A. William Pasculle, Ellen G. Press, Ghady Haidar, Binghua Hao, Liang Chen, Barry N. Kreiswirth, M. Hong Nguyen
出版 2017Artigo -
14
Emergence of high-level aztreonam–avibactam and cefiderocol resistance following treatment of an NDM-producing <i>Escherichia coli</i> bloodstream isolate exhibiting reduced suscep... 由 Ghady Haidar, Ellen G Kline, Georgios D. Kitsios, Xiaohong Wang, E.J. Kwak, Anthony Newbrough, K J Friday, Kailey Hughes Kramer, Ryan K. Shields
出版 2024Artigo -
15
Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1. 由 Ryan K. Shields, Brian A. Potoski, Ghady Haidar, Binghua Hao, Yohei Doi, Liang Chen, Ellen G. Press, Barry N. Kreiswirth, Cornelius J. Clancy, M. Hong Nguyen
出版 2016Artigo -
16
Rates of Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam Among Patients Treated for Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Bacteremia or Pneumonia 由 Sunish Shah, Ellen G Kline, Ghady Haidar, Kevin M Squires, Jason M. Pogue, Erin K. McCreary, Justin Ludwig, Lloyd Clarke, Madison Stellfox, Daria Van Tyne, Ryan K. Shields
出版 2024Artigo -
17
<i>In Vitro</i> Susceptibility of Multidrug-Resistant Pseudomonas aeruginosa following Treatment-Emergent Resistance to Ceftolozane-Tazobactam 由 Abigail M Rubio, Ellen G Kline, Chelsea E Jones, Liang Chen, Barry N. Kreiswirth, M. Hong Nguyen, Cornelius J. Clancy, Vaughn S. Cooper, Ghady Haidar, Daria Van Tyne, Ryan K. Shields
出版 2021Artigo -
18
Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of Resistance 由 Ghady Haidar, Nathan J Philips, Ryan K. Shields, Daniel J. Snyder, Shaoji Cheng, Brian A. Potoski, Yohei Doi, Binghua Hao, Ellen G. Press, Vaughn S. Cooper, Cornelius J. Clancy, M. Hong Nguyen
出版 2017Artigo -
19
Metagenomic identification of severe pneumonia pathogens in mechanically-ventilated patients: a feasibility and clinical validity study 由 Libing Yang, Ghady Haidar, Haris Zia, Rachel Nettles, Shulin Qin, Xiaohong Wang, Faraaz Shah, Sarah F. Rapport, Themoula Charalampous, Barbara A. Methé, Adam Fitch, Alison Morris, Bryan J. McVerry, Justin O’Grady, Georgios D. Kitsios
出版 2019Artigo -
20
Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection 由 J Ryan Bariola, Erin K McCreary, Richard J. Wadas, Kevin E. Kip, Oscar C. Marroquin, Tami Minnier, Stephen Koscumb, Kevin Collins, Mark Schmidhofer, Judith A. Shovel, Mary Kay Wisniewski, Colleen Sullivan, Donald M. Yealy, David A. Nace, David T. Huang, Ghady Haidar, Tina Khadem, Kelsey Linstrum, Christopher Seymour, Stephanie K. Montgomery, Derek C. Angus, Graham M. Snyder
出版 2021Artigo
相关主题
Medicine
Biology
Internal medicine
Genetics
Microbiology
Immunology
Antibiotics
Disease
Bacteria
Virology
Coronavirus disease 2019 (COVID-19)
Gene
Infectious disease (medical specialty)
Pseudomonas aeruginosa
Ceftazidime/avibactam
Antibody
Ceftazidime
Escherichia coli
Immune system
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
2019-20 coronavirus outbreak
Antibiotic resistance
Avibactam
Imipenem
Intensive care medicine
Outbreak
Virus
Confidence interval
Coronavirus
Enterobacteriaceae